Invention Grant
- Patent Title: MK2 inhibitors
- Patent Title (中): MK2抑制剂
-
Application No.: US13514865Application Date: 2010-12-13
-
Publication No.: US08772286B2Publication Date: 2014-07-08
- Inventor: Tjeerd Andries Barf , Arthur Oubrie , Carsten Schultz-Fademrecht , Eduard Willem Zwart , Niels Hoogenboom , Sander Martijn De Wilde , Allard Kaptein
- Applicant: Tjeerd Andries Barf , Arthur Oubrie , Carsten Schultz-Fademrecht , Eduard Willem Zwart , Niels Hoogenboom , Sander Martijn De Wilde , Allard Kaptein
- Applicant Address: NL Haarlem
- Assignee: Merck Sharp & Dohme B.V.
- Current Assignee: Merck Sharp & Dohme B.V.
- Current Assignee Address: NL Haarlem
- Agent Maria V. Marucci; Valerie J. Camara
- Priority: EP09179043 20091214
- International Application: PCT/EP2010/069465 WO 20101213
- International Announcement: WO2011/073119 WO 20110623
- Main IPC: A61K31/535
- IPC: A61K31/535
Abstract:
The present invention relates to compounds of general Formula (I) or a pharmaceutically acceptable salt thereof. The compounds can be used in the treatment of immune, autoimmune, inflammatory diseases, cardiovascular diseases, infectious diseases, bone resorption disorders, neurodegenerative diseases or proliferative diseases.
Public/Granted literature
- US20120245175A1 MK2 INHIBITORS Public/Granted day:2012-09-27
Information query
